Neumora Therapeutics Inc.... (NMRA)
NASDAQ: NMRA
· Real-Time Price · USD
1.62
0.04 (2.53%)
At close: Aug 15, 2025, 3:59 PM
1.66
2.47%
After-hours: Aug 15, 2025, 07:51 PM EDT
Neumora Therapeutics Common Stock Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 318K | 478K | 636K | 484K | 1.51M | 2.34M | 3.14M | 3.9M | 3.8M | 3.29M | 2.7M | 1.77M | 848K | 369K | 315K | 315K | 315K | 315K |
Gross Profit | n/a | -160K | -318K | -484K | -1.51M | -2.34M | -3.14M | -3.9M | -3.8M | -3.29M | -2.7M | -1.77M | -848K | -369K | -315K | -315K | -315K | -315K |
Operating Income | -264.54M | -274.33M | -263.46M | -314.55M | -294.76M | -273M | -252.1M | -168.81M | -142.55M | -131.8M | -135.87M | -131.7M | -279.23M | -265.11M | -237.32M | -230.3M | -52.17M | -34.97M |
Interest Income | 11.37M | 16.64M | 19.93M | 21.49M | 21.12M | 19.41M | 16.61M | 13.25M | 10.82M | 8.04M | 4.56M | 2.28M | 870K | 86K | n/a | n/a | n/a | n/a |
Pretax Income | -251.91M | -257.77M | -243.61M | -293.25M | -273.79M | -253.75M | -235.66M | -155.34M | -131.66M | -123.49M | -130.9M | -129.73M | -278.41M | -265.05M | -237.31M | -230.34M | -52.31M | -35.3M |
Net Income | -252.09M | -258.06M | -243.79M | -293.7M | -274.18M | -254.02M | -235.93M | -155.34M | -131.66M | -123.49M | -130.9M | -129.73M | -278.41M | -265.05M | -237.31M | -230.34M | -52.31M | -35.3M |
Selling & General & Admin | 67.13M | 67M | 62.54M | 56.76M | 56.01M | 50.11M | 45.48M | 41.43M | 34.22M | 32.72M | 31.12M | 31.56M | 30.17M | 28.69M | 24.55M | 21.2M | 14.54M | 8.24M |
Research & Development | 197.42M | 207.32M | 200.93M | 257.78M | 238.75M | 222.9M | 206.62M | 127.38M | 108.33M | 99.08M | 104.75M | 100.14M | 249.06M | 236.42M | 212.78M | 209.1M | 37.63M | 26.74M |
Other Expenses | n/a | n/a | -12K | -116K | -117K | -156K | -170K | 221K | 74K | 271K | 405K | 118K | 369K | 211K | 244K | 244K | 141K | 141K |
Operating Expenses | 264.54M | 274.33M | 263.46M | 314.55M | 294.76M | 273M | 252.1M | 168.81M | 142.55M | 131.8M | 135.87M | 131.7M | 279.23M | 265.11M | 237.32M | 230.3M | 52.17M | 34.97M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 210.82M | 274.64M | 263.78M | 314.55M | 294.76M | 273M | 252.1M | 168.81M | 142.55M | 131.8M | 135.87M | 131.7M | 279.23M | 265.11M | 237.32M | 230.3M | 52.17M | 34.97M |
Income Tax Expense | 183K | 283K | 178K | -5.2M | -5.25M | -5.38M | -5.38M | n/a | n/a | n/a | -86K | -86K | -86K | -86K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 161.69M | 161.45M | 160.98M | 159.58M | 158.98M | 157.94M | 158.83M | 155.39M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M |
Shares Outstanding (Diluted) | 161.69M | 161.45M | 160.98M | 159.58M | 158.98M | 157.94M | 158.83M | 155.39M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M |
EPS (Basic) | -1.57 | -1.61 | -1.53 | -1.84 | -1.73 | -1.61 | -1.5 | -1.01 | -0.86 | -0.81 | -0.86 | -0.85 | -1.83 | -1.74 | -1.56 | -1.51 | -0.34 | -0.23 |
EPS (Diluted) | -1.57 | -1.61 | -1.53 | -1.84 | -1.73 | -1.61 | -1.5 | -1.01 | -0.86 | -0.81 | -0.86 | -0.85 | -1.83 | -1.74 | -1.56 | -1.51 | -0.34 | -0.23 |
EBITDA | -264.23M | -273.85M | -262.83M | -300.36M | -279.71M | -257.12M | -235.42M | -164.91M | -138.75M | -128.52M | -133.4M | -130.02M | -278.32M | -264.56M | -236.6M | -229.65M | -51.67M | -34.59M |
EBIT | -264.54M | -274.33M | -263.46M | -314.55M | -294.76M | -273M | -252.1M | -168.81M | -142.55M | -131.8M | -135.87M | -131.7M | -279.23M | -265.11M | -237.32M | -230.3M | -52.17M | -34.97M |
Depreciation & Amortization | 470K | 630K | 631K | 640K | 1.51M | 2.34M | 3.14M | 3.9M | 3.8M | 3.29M | 2.7M | 1.9M | 1.13M | 775K | 721K | 653K | 503K | 378K |